High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)

NCT07285369 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor stopped the study

Conditions

Gaucher Disease, Type 3

Interventions

DRUG: Ambroxol

Sponsor

Agyany Pharma LTD